Altimmune, Inc.

$10.42
ALT - NASDAQ
Dividend yield
Average yield for past twelve months.
-
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
Altimmune, Inc. last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile ALT stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Altimmune, Inc. have in comparison to other dividend stocks
Become our supporter to unlock all data!
Altimmune, Inc. description

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Company profile
Market cap
Micro (209.56M)
Company CEO
Vipin K. Garg
Price history Altimmune, Inc.
Loading price stock history...
ALT dividends payouts
Similar stocks as Altimmune, Inc.